Neonc Technologies Holdings NTHI
NASDAQ NTHI
$4.68 +0.12 (+2.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neonc Technologies Holdings (NTHI) Cash from Financing Activities (2024 - 2026)

Neonc Technologies Holdings (NTHI) posted quarterly Cash from Financing Activities of $7.1 million for Q1 2026, down 35.85% year-over-year from $11.0 million in Q1 2025, and up 168.2% quarter-over-quarter from $2.6 million in Q4 2025.

Neonc Technologies Holdings (NTHI) Cash from Financing Activities (2024 - 2026) Analysis & Trends

Neonc Technologies Holdings (NTHI) has reported Cash from Financing Activities for 3 consecutive years, with $7.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash from Financing Activities fell 35.85% year-over-year to $7.1 million; the TTM figure through Mar 2026 stood at $16.9 million (up 9.46% YoY), while the FY2025 annual figure was $20.9 million, up 391.12% from the prior year.
  • Cash from Financing Activities advanced to $7.1 million in Q1 2026 per NTHI's latest filing, from $2.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $11.0 million in Q1 2025 and bottomed at -$315330.0 in Q4 2024.
  • Historically, Cash from Financing Activities has averaged $4.0 million across 3 years, with a median of $2.8 million in 2024.
  • Annual changes were most pronounced in 2025 — Cash from Financing Activities jumped 6487.42% — and 2026, when it plunged 35.85%.
  • Neonc Technologies Holdings' Cash from Financing Activities stood at -$315330.0 in 2024, then soared by 936.16% to $2.6 million in 2025, then surged by 168.2% to $7.1 million in 2026.
  • Business Quant data shows NTHI's Cash from Financing Activities at $7.1 million in Q1 2026, $2.6 million in Q4 2025, and $7.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -426.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn -1.22 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 14.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn -6.05 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 36.24 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -16.65 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 27.18 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -273.15 Mn
10 Neonc Technologies Holdings 116.41 Mn 116.41 Mn - 6.60 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 6.60 Mn
Jun 30, 2026 6.60 Mn
Mar 31, 2026 7.07 Mn
Mar 31, 2026 7.07 Mn
Dec 31, 2025 2.64 Mn
Dec 31, 2025 2.64 Mn
Sep 30, 2025 7.20 Mn
Sep 30, 2025 7.20 Mn
Mar 31, 2025 11.02 Mn
Mar 31, 2025 11.02 Mn
Dec 31, 2024 -315,330.00
Dec 31, 2024 -315,330.00
Sep 30, 2024 2.89 Mn
Sep 30, 2024 2.89 Mn
Jun 30, 2024 1.85 Mn
Jun 30, 2024 1.85 Mn
Mar 31, 2024 -172,595.00
Mar 31, 2024 -172,595.00